SCHEMBL594652

SCHEMBL594652

CCC(C(=O)O)C(=O)C1CCC2(CC1)OCCO2

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.40
MAPK1 P28482 2/20 0.40
LMNA P02545 1/20 0.40
ALDH1A1 P00352 6/20 0.39
TSHR P16473 3/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CTSS P25774 1/20 0.38
CTSK P43235 1/20 0.38
KMT2A Q03164 6/20 0.35
C5AR1 P21730 1/20 0.34
POLB P06746 1/20 0.34
MEN1 O00255 4/20 0.32
CYP2C19 P33261 2/20 0.32
NPC1 O15118 1/20 0.31
CASP1 P29466 1/20 0.31
RAB9A P51151 1/20 0.31
CASP7 P55210 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL594110 0.91 SMN1; SMN2 (0.36) SMN1; SMN2MAPK1LMNAALDH1A1TSHR
SCHEMBL20624957 0.82 SMN1; SMN2 (0.43) SMN1; SMN2MAPK1LMNAALDH1A1TSHR
SCHEMBL3493673 0.78 TP53 (0.35) MAPK1LMNAL3MBTL1
SCHEMBL15996143 0.75 ALDH1A1 (0.40) SMN1; SMN2MAPK1LMNAALDH1A1TSHR
SCHEMBL25929815 0.75 CTSS (0.40) SMN1; SMN2MAPK1LMNAALDH1A1TSHR
SCHEMBL15069494 0.74 MAPK1 (0.44) SMN1; SMN2MAPK1LMNAALDH1A1TSHR
SCHEMBL2203295 0.73 LMNA (0.41) SMN1; SMN2MAPK1LMNAALDH1A1TSHR
SCHEMBL347049 0.73 TSHR (0.41) MAPK1LMNAALDH1A1TSHRL3MBTL1
SCHEMBL5618 0.70 CYP3A4 (0.49) SMN1; SMN2MAPK1LMNAALDH1A1POLB
SCHEMBL594661 0.69 ALDH1A1 (0.38) SMN1; SMN2MAPK1LMNAALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2448942-A1 FUSED TRICYCLIC COMPOUNDS AS NOVEL mTOR INHIBITORS Schering Corporation (US) 2012-05-09 EP disclosed
EP-2417138-A1 PYRAZOLO [1, 5-A] PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS Schering Corporation (US) 2012-02-15 EP disclosed
WO-2011002887-A1 FUSED TRICYCLIC COMPOUNDS AS NOVEL mTOR INHIBITORS SCHERING CORPORATION (US) 2011-01-06 WO disclosed
WO-2010118207-A1 PYRAZOLO [1, 5-A] PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS SCHERING CORPORATION (US) 2010-10-14 WO disclosed